Publication | Open Access

Preexisting autoimmune disease and immune-related adverse events associated with anti-PD-1 cancer immunotherapy: a national case series from the Canadian Research Group of Rheumatology in Immuno-Oncology

RheumatologyCancer ImmunosurveillanceAutoimmune DiseaseAllergyNational Case SeriesMedicineRheumatic DiseasesImmunologyImmune Checkpoint InhibitorAutoimmunityAutoantibodiesInflammatory Rheumatic DiseaseAnti-pd-1 Cancer ImmunotherapyImmunotherapyOncologyRheumatoid Arthritis